ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2026-08-17–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Zoetis Inc. publishes a filing, an earnings call transcript or a press release.
Get ZTS alertsJames (Jay) Saccaro is recorded as CFO at Zoetis Inc. (ZTS) since August 17, 2026. Zoetis Inc. reported in an 8-K filed August 6, 2026 that James (Jay) Saccaro was appointed Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. James (Jay) Saccaro has spoken on 1 earnings call across 1 company, most recently for Zoetis Inc. on November 5, 2026. Zoetis Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Zoetis Inc. includes Juan Ramón Alaix (CEO), James Saccaro (CFO and COO), Roxanne Lagano (General Counsel) and 7 others.
“Zoetis Inc. (NYSE: ZTS) today announced the appointment of James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026.”
“I'm excited to be here for my first earnings call with Zoetis. And while I'm just a few months in, my conviction in this company has only grown.”
2026-08-17–present
ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2026-08-17–present